Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
Video Player is loading.

1x

00:00
Current Time 0:00
/
Duration -:-
00:00
00:00
/ 
00:50
Stream Type LIVE
 
1x
  • 2x
  • 1.5x
  • 1x, selected
  • 0.75x
  • 0.5x
  • Chapters
  • descriptions off, selected
  • captions settings, opens captions settings dialog
  • captions off, selected

    This is a modal window.

    The media could not be loaded, either because the server or network failed, or because the format is not supported, or asset is still processing.

    Beginning of dialog window. Escape will cancel and close the window.

    Text
    Background
    Window
    Font Size
    Text Edge Style
    Font Family

    End of dialog window.

  • Get link
    • doctype icon
    Conceptually similar
    3rd major COVID-19 vaccine shown to be effective
    play button
    CP112067360 | 3rd major COVID-19 vaccine shown to be effective 
    What to know about Johnson & Johnson's COVID-19 vaccine
    play button
    CP119565630 | What to know about Johnson & Johnson's COVID-19 vaccine 
    Nearly one million COVID-19 vaccine doses arriving in Canada this week: Anand
    play button
    CP119321831 | Nearly one million COVID-19 vaccine doses arriving in Canada this week: Anand 
    All approved COVID-19 vaccines safe, effective: Trudeau
    play button
    CP122770871 | All approved COVID-19 vaccines safe, effective: Trudeau 
    Ghana 1st nation to receive vaccines from COVAX
    play button
    CP118800860 | Ghana 1st nation to receive vaccines from COVAX 
    Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
    play button
    CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine 
    Ontario to offer vaccines to residents 75 and older
    play button
    CP120269571 | Ontario to offer vaccines to residents 75 and older 
    Newly eligible people receive Oxford-AstraZeneca vaccine
    play button
    CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine 
    Feds defend not donating Pfizer, Moderna vaccines to poor countries
    play button
    CP126934421 | Feds defend not donating Pfizer, Moderna vaccines to poor countries 
    AstraZeneca vaccine authorized in Canada
    play button
    CP118971421 | AstraZeneca vaccine authorized in Canada 
    Action button

    Trial participants react to news on COVID vaccine

    Three participants in the AstraZeneca clinical trial for the COVID-19 vaccine say news that the vaccine produced by Pfizer Inc. may be 90% effective is encouraging and they are all a team, no matter who finishes first. (Nov. 10) 
    Actions
     Add to collection
     Add to cart
    Information
    Source name: 
    The Associated Press
    Unique identifier: CP111599521 
    Legacy Identifier: fd272c4f736649edb344f1bad53aab18 
    Type: Video 
    Duration: 50s 
    Dimensions: 1920px × 1080px     62.19 MB 
    Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
    Create Date: 11/10/2020 2:57:39 PM 
    Display aspect ratio: 16:9